| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.2 | 0.4 |